Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Auditor change
Appointed director

Eidos Therapeutics, Inc. (EIDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/28/2021 4 Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Gifted 500 shares @ $0
Unknown transaction of 380,467 shares @ $0
Disposed/sold 70,000 options to buy @ $13.2, valued at $924k
01/28/2021 4 Rohlen Douglas (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Disposed/sold 21,447 options to buy @ $41.42, valued at $888.3k
Disposed/sold 4,526 restricted stock units @ $0
01/28/2021 4 Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Disposed/sold 24,350 options to buy @ $7.24, valued at $176.3k
01/28/2021 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Unknown transaction of 50,699 shares @ $0
Disposed/sold 9,469 options to buy @ $17, valued at $161k
Disposed/sold 53,157 options to buy @ $13.2, valued at $701.7k
01/28/2021 4 Satvat Ali J. (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Disposed/sold 21,528 options to buy @ $48.51, valued at $1M
Disposed/sold 21,528 options to buy @ $30.87, valued at $664.6k
Disposed/sold 43,056 options to buy @ $20.34, valued at $875.8k
01/28/2021 4 Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Disposed/sold 21,528 options to buy @ $48.51, valued at $1M
Disposed/sold 21,528 options to buy @ $30.87, valued at $664.6k
Disposed/sold 43,056 options to buy @ $13.67, valued at $588.6k
01/28/2021 4 Hooper Suzanne Sawochka (Director) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Disposed/sold 21,447 options to buy @ $41.42, valued at $888.3k
Disposed/sold 4,526 restricted stock units @ $0
01/28/2021 4 Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Gifted 3,000 shares @ $0
Unknown transaction of 303,525 shares @ $0
Disposed/sold 60,000 options to buy @ $13.2, valued at $792k
01/26/2021 4 BridgeBio Pharma, Inc. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Bought 14,428,836 shares @ $0
01/15/2021 4 Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 696 shares @ $121.1094, valued at $84.3k
Sold 572 shares @ $122.2667, valued at $69.9k
Sold 1,498 shares @ $123.4787, valued at $185k
Sold 4,934 shares @ $124.7187, valued at $615.4k
Sold 2,000 shares @ $125.35, valued at $250.7k
Sold 300 shares @ $126.39, valued at $37.9k
01/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 3,756 shares @ $110.2906, valued at $414.3k
Sold 7,600 shares @ $111.3075, valued at $845.9k
Sold 11,445 shares @ $112.1903, valued at $1.3M
Sold 3,493 shares @ $112.9657, valued at $394.6k
Exercised 4,451 options to buy @ $17, valued at $75.7k
Exercised 21,843 options to buy @ $13.2, valued at $288.3k
12/04/2020 4 Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 3,798 shares @ $89.6267, valued at $340.4k
Sold 702 shares @ $90.6339, valued at $63.6k
Sold 300 shares @ $91.89, valued at $27.6k
Sold 200 shares @ $92.965, valued at $18.6k
11/13/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 3,005 shares @ $73.564, valued at $221.1k
Sold 9,497 shares @ $74.7457, valued at $709.9k
Sold 908 shares @ $75.2286, valued at $68.3k
Gifted 1,500 shares @ $0
11/10/2020 4 Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 1,623 shares @ $74.9287, valued at $121.6k
Exercised 1,623 options to buy @ $7.24, valued at $11.8k
11/03/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 9,145 shares @ $70.4438, valued at $644.2k
Sold 3,146 shares @ $71.4167, valued at $224.7k
Sold 209 shares @ $72.0961, valued at $15.1k
Exercised 5,000 options to buy @ $13.2, valued at $66k
Exercised 2,500 options to buy @ $17, valued at $42.5k
10/30/2020 4 Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 1,300 shares @ $71.9024, valued at $93.5k
Sold 3,700 shares @ $72.6016, valued at $268.6k
10/09/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2020 4 Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 69 shares @ $52.08, valued at $3.6k
Sold 100 shares @ $52, valued at $5.2k
Sold 4,831 shares @ $52.3542, valued at $252.9k
09/18/2020 4 Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 5,767 shares @ $50.1576, valued at $289.3k
09/16/2020 4 Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 111 shares @ $50, valued at $5.6k
Sold 1,000 shares @ $50.064, valued at $50.1k
Sold 3,122 shares @ $50.1632, valued at $156.6k
09/11/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 2,500 shares @ $47, valued at $117.5k
Exercised 2,500 options to buy @ $17, valued at $42.5k
08/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/10/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/09/2020 4 Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 5,000 shares @ $50, valued at $250k
07/01/2020 4 Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Acquired 1,088 shares @ $0
06/05/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 376 shares @ $41.5735, valued at $15.6k
06/05/2020 4 Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 444 shares @ $41.5735, valued at $18.5k
Gifted 1,020 shares @ $0
Gifted 1,020 shares @ $0
Sold 5,000 shares @ $50, valued at $250k
06/05/2020 4 Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 444 shares @ $41.5735, valued at $18.5k
06/05/2020 4 Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 444 shares @ $41.5735, valued at $18.5k
06/01/2020 4 Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 5,000 shares @ $50, valued at $250k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy